Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

Strategies for cardiac repair include injection of cells, but these approaches have been hampered by poor cell engraftment, survival, and differentiation. To address these shortcomings for the purpose of improving cardiac function after injury, we designed self-assembling peptide nanofibers for prolonged delivery of insulin-like growth factor 1 (IGF-1), a cardiomyocyte growth and differentiation factor, to the myocardium, using a "biotin sandwich" approach. Biotinylated IGF-1 was complexed with tetravalent streptavidin and then bound to biotinylated self-assembling peptides. This biotin sandwich strategy allowed binding of IGF-1 but did not prevent self-assembly of the peptides into nanofibers within the myocardium. IGF-1 that was bound to peptide nanofibers activated Akt, decreased activation of caspase-3, and increased expression of cardiac troponin I in cardiomyocytes. After injection into rat myocardium, biotinylated nanofibers provided sustained IGF-1 delivery for 28 days, and targeted delivery of IGF-1 in vivo increased activation of Akt in the myocardium. When combined with transplanted cardiomyocytes, IGF-1 delivery by biotinylated nanofibers decreased caspase-3 cleavage by 28% and increased the myocyte cross-sectional area by 25% compared with cells embedded within nanofibers alone or with untethered IGF-1. Finally, cell therapy with IGF-1 delivery by biotinylated nanofibers improved systolic function after experimental myocardial infarction, demonstrating how engineering the local cellular microenvironment can improve cell therapy.

[1]  Q. Li,et al.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.

[2]  R. Solaro,et al.  Differential expression of TnI and TnT isoforms in rabbit heart during the perinatal period and during cardiovascular stress. , 1995, Journal of molecular and cellular cardiology.

[3]  K. Manova,et al.  Rescue of Cardiac Defects in Id Knockout Embryos by Injection of Embryonic Stem Cells , 2004, Science.

[4]  Mark A Sussman,et al.  Cardiac Stem Cell and Myocyte Aging, Heart Failure, and Insulin-Like Growth Factor-1 Overexpression , 2004, Circulation research.

[5]  Richard T. Lee,et al.  Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. , 2005, The Journal of clinical investigation.

[6]  I. Weissman,et al.  Insulin‐Like Growth Factor Promotes Engraftment, Differentiation, and Functional Improvement after Transfer of Embryonic Stem Cells for Myocardial Restoration , 2004, Stem cells.

[7]  Roger D Kamm,et al.  Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence. , 2002, Biomaterials.

[8]  Shuguang Zhang.  Fabrication of novel biomaterials through molecular self-assembly , 2003, Nature Biotechnology.

[9]  Richard T. Lee,et al.  Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.

[10]  Y. Fujio,et al.  Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent Manner* , 1999, The Journal of Biological Chemistry.

[11]  Richard T. Lee,et al.  Custom Design of the Cardiac Microenvironment With Biomaterials , 2005, Circulation research.

[12]  Ashutosh Chilkoti,et al.  Effect of streptavidin affinity mutants on the integrin-independent adhesion of biotinylated endothelial cells. , 2003, Biomaterials.

[13]  P. Menasché.  Cellular transplantation: hurdles remaining before widespread clinical use , 2004, Current opinion in cardiology.

[14]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[15]  Wonmuk Hwang,et al.  Design of nanostructured biological materials through self-assembly of peptides and proteins. , 2002, Current opinion in chemical biology.

[16]  A. Rich,et al.  Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Ashutosh Chilkoti,et al.  Control of protein–ligand recognition using a stimuli-responsive polymer , 1995, Nature.

[18]  J. Ingwall,et al.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts , 2003, Nature Medicine.

[19]  Richard W. Orrell,et al.  Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.[see comment] , 2003 .

[20]  P. Doevendans,et al.  Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. , 2001, Cardiovascular research.

[21]  I. Martin,et al.  Direct visualization of ligand‐protein interactions using atomic force microscopy , 2002, British journal of pharmacology.

[22]  J L Sussman,et al.  Three-dimensional structures of avidin and the avidin-biotin complex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R W Orrell,et al.  Expression of IGF‐I splice variants in young and old human skeletal muscle after high resistance exercise , 2003, The Journal of physiology.

[24]  A Coda,et al.  Three-dimensional structure of the tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 A resolution. , 1993, Journal of molecular biology.

[25]  P. Menasché.  Cell transplantation in myocardium. , 2003, The Annals of thoracic surgery.